Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Cara Therapeutics (NQ: CARA)
19.13 USD  -0.56 (-2.84%)
Official Closing Price  /  Updated: 4:44 PM EDT, Oct 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 396,500
Open 19.60
Bid (Size) 18.95 (3)
Ask (Size) 23.97 (2)
Prev. Close 19.69
Today's Range 18.95 - 19.61
52wk Range 12.19 - 27.55
Shares Outstanding 33,874,770
Dividend Yield N/A
Performance
YTD
+31.39%
+31.39%
1 Month
-16.61%
-16.61%
3 Month
-26.02%
-26.02%
6 Month
+8.08%
+8.08%
1 Year
-2.75%
-2.75%
Top News
More News
Cara Therapeutics Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Phase 3 Global Trial of KORSUVA™ Injection in Hemodialysis Patients with Pru
from GlobeNewswire News Releases
Cara Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
from GlobeNewswire News Releases
More News
Read More
SWK Holdings Corporation Files Application for Uplisting to NASDAQ Capital Market
from PR Newswire
Enteris BioPharma and Cara Therapeutics Enter into Licensing Agreement for Peptelligence® to Advance Development of Oral KORSUVA™
from PR Newswire
Cara Therapeutics Enters into Commercial License Agreement with Enteris BioPharma, Inc. for Peptelligence® Oral Formulation Technology
from GlobeNewswire News Releases
Cara Therapeutics Reports Second Quarter 2019 Financial Results
from GlobeNewswire News Releases
Cara Therapeutics Breaks Above 200-Day Moving Average - Bullish for CARA
category Stocks
from Market News Video
Cara Therapeutic Down 11.3% Since SmarTrend Downtrend Call (CARA)
from Comtex SmarTrend® News Briefs
Surprising Analyst 12-Month Target For IUSS
category ETFs
from ETF Channel
13.4% Return Seen to Date on SmarTrend Cara Therapeutic Call (CARA)
from Comtex SmarTrend® News Briefs
Noteworthy Tuesday Option Activity: TRTX, CARA, WDAY
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.